FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2072463499> ?p ?o ?g. }

• W2072463499 endingPage "327" @default.
• W2072463499 startingPage "319" @default.
• W2072463499 abstract "To assess treatment outcome after definitive radiotherapy for Stage III cervical carcinoma retrospective analysis of the clinical data was performed.We enrolled 265 patients with Stage III cervical carcinoma who were treated with combined external beam radiotherapy [mean +/- standard deviation (SD), 50.3 +/- 1.8 Gy; range 40-70) and intracavitary brachytherapy (ICBT) (mean +/- SD, 19.8 +/- 2.4 Gy; range 10-32) using a high-dose-rate 60Co source. We retrospectively analyzed, as measures of the therapeutic outcome, the overall survival rate (OAS), relapse-free survival rate (RFS), locoregional event-free rate (LREF), distant metastasis (DM), and late complication.The 5-year OAS, RFS, and LREF rates (n = 265) were 50.7%, 57.1%, and 71.2%, respectively. Univariate analysis revealed a significant favorable effect on the OAS rate for complete response (CR) (p = 0.024), maximum tumor diameter < 6 cm (SML) (p = 0.0009), Karnofsky performance score > or =70 (p = 0.046), age <75 years (p = 0.0043), hemoglobin (Hb) concentration of > or =9 g/dl (p = 0.0005), and histopathological diagnosis of squamous cell carcinoma (SCC) (p = 0.0089). In the multivariate analysis, Hb, SCC, SML, and CR remained significant prognostic factors. In both univariate and multivariate analysis, SML, Hb, age, and SCC showed significant effects on the RFS rate. Age > or =60 years (p = 0.017), Hb > or =9 g/dl (p = 0.0039), and SML (p = 0.0046) were significant favorable prognostic factors for the LREF rate identified by univariate analysis. In addition, advanced age, SML, and SCC showed significant beneficial effects on the LREF rate in the multivariate analysis. DM developed in 21.1% of patients, and the groups with Hb < 9 g/dl (p < 0.005), Karnofsky performance score of <70 (p < 0.001), and dose at point A in the ICBT < 16 Gy (p < 0.005) developed a significantly greater incidence of DM than did the groups without. The 5-year incidence was 2.6% for major bladder complication and 8.3% for major rectal complication. The radiation dose in the subgroup with rectal complication was significantly greater than that in the subgroup without complications.In patients with Stage III cervical carcinoma, tumor size, concentration of Hb, and histopathological diagnosis are strong prognostic factors for the therapeutic outcome. The ICBT dose in our study was small compared to the reported data, but the outcome was quite comparable. Thus, the dose we used might be the minimum required. However, locoregional control still remains an important problem. It is necessary to attain the optimal dose distribution in both the target volume and in critical organs. In high-risk patients, combined use of chemotherapy is crucial to improve the response to radiation." @default.
• W2072463499 created "2016-06-24" @default.
• W2072463499 creator A5019871387 @default.
• W2072463499 creator A5020504658 @default.
• W2072463499 creator A5046628885 @default.
• W2072463499 creator A5060609402 @default.
• W2072463499 creator A5066700160 @default.
• W2072463499 creator A5073001440 @default.
• W2072463499 creator A5076420669 @default.
• W2072463499 date "1998-05-01" @default.
• W2072463499 modified "2023-09-25" @default.
• W2072463499 title "Definitive Radiotherapy Combined with High-Dose-Rate Brachytherapy for Stage III Carcinoma of the Uterine Cervix: Retrospective Analysis of Prognostic Factors Concerning Patient Characteristics and Treatment Parameters" @default.
• W2072463499 cites W1980067928 @default.
• W2072463499 cites W1980752105 @default.
• W2072463499 cites W1982472596 @default.
• W2072463499 cites W1987508694 @default.
• W2072463499 cites W1991657799 @default.
• W2072463499 cites W1998866061 @default.
• W2072463499 cites W2002117503 @default.
• W2072463499 cites W2006293516 @default.
• W2072463499 cites W2014501764 @default.
• W2072463499 cites W2019108616 @default.
• W2072463499 cites W2020141735 @default.
• W2072463499 cites W2029856598 @default.
• W2072463499 cites W2036758816 @default.
• W2072463499 cites W2039657002 @default.
• W2072463499 cites W2043108933 @default.
• W2072463499 cites W2045890107 @default.
• W2072463499 cites W2047052952 @default.
• W2072463499 cites W2049196848 @default.
• W2072463499 cites W2054012747 @default.
• W2072463499 cites W2054294648 @default.
• W2072463499 cites W2061918705 @default.
• W2072463499 cites W2068166893 @default.
• W2072463499 cites W2070220337 @default.
• W2072463499 cites W2072109574 @default.
• W2072463499 cites W2072199736 @default.
• W2072463499 cites W2073146085 @default.
• W2072463499 cites W2074802560 @default.
• W2072463499 cites W2084612222 @default.
• W2072463499 cites W2090186293 @default.
• W2072463499 cites W2107229429 @default.
• W2072463499 cites W2115146864 @default.
• W2072463499 cites W2122169072 @default.
• W2072463499 cites W2143609123 @default.
• W2072463499 cites W2149939825 @default.
• W2072463499 cites W2152292894 @default.
• W2072463499 cites W2171249276 @default.
• W2072463499 cites W2333609993 @default.
• W2072463499 doi "https://doi.org/10.1016/s0360-3016(98)00053-4" @default.
• W2072463499 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/9607347" @default.
• W2072463499 hasPublicationYear "1998" @default.
• W2072463499 type Work @default.
• W2072463499 sameAs 2072463499 @default.
• W2072463499 citedByCount "35" @default.
• W2072463499 countsByYear W20724634992013 @default.
• W2072463499 countsByYear W20724634992014 @default.
• W2072463499 countsByYear W20724634992015 @default.
• W2072463499 countsByYear W20724634992018 @default.
• W2072463499 countsByYear W20724634992019 @default.
• W2072463499 countsByYear W20724634992021 @default.
• W2072463499 crossrefType "journal-article" @default.
• W2072463499 hasAuthorship W2072463499A5019871387 @default.
• W2072463499 hasAuthorship W2072463499A5020504658 @default.
• W2072463499 hasAuthorship W2072463499A5046628885 @default.
• W2072463499 hasAuthorship W2072463499A5060609402 @default.
• W2072463499 hasAuthorship W2072463499A5066700160 @default.
• W2072463499 hasAuthorship W2072463499A5073001440 @default.
• W2072463499 hasAuthorship W2072463499A5076420669 @default.
• W2072463499 hasConcept C126322002 @default.
• W2072463499 hasConcept C126894567 @default.
• W2072463499 hasConcept C143998085 @default.
• W2072463499 hasConcept C144301174 @default.
• W2072463499 hasConcept C146357865 @default.
• W2072463499 hasConcept C151730666 @default.
• W2072463499 hasConcept C167135981 @default.
• W2072463499 hasConcept C2775908122 @default.
• W2072463499 hasConcept C2776283816 @default.
• W2072463499 hasConcept C2777416452 @default.
• W2072463499 hasConcept C2777546739 @default.
• W2072463499 hasConcept C2989005 @default.
• W2072463499 hasConcept C38180746 @default.
• W2072463499 hasConcept C509974204 @default.
• W2072463499 hasConcept C71924100 @default.
• W2072463499 hasConcept C86803240 @default.
• W2072463499 hasConcept C90924648 @default.
• W2072463499 hasConceptScore W2072463499C126322002 @default.
• W2072463499 hasConceptScore W2072463499C126894567 @default.
• W2072463499 hasConceptScore W2072463499C143998085 @default.
• W2072463499 hasConceptScore W2072463499C144301174 @default.
• W2072463499 hasConceptScore W2072463499C146357865 @default.
• W2072463499 hasConceptScore W2072463499C151730666 @default.
• W2072463499 hasConceptScore W2072463499C167135981 @default.
• W2072463499 hasConceptScore W2072463499C2775908122 @default.
• W2072463499 hasConceptScore W2072463499C2776283816 @default.
• W2072463499 hasConceptScore W2072463499C2777416452 @default.
• W2072463499 hasConceptScore W2072463499C2777546739 @default.
• W2072463499 hasConceptScore W2072463499C2989005 @default.

• next